Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
GoHealth (GOCO) has provided an update.
Joseph G. Flanagan has announced his resignation from the GoHealth, Inc. Board of Directors, effective June 25, 2024. During his tenure, Flanagan held key roles including Chairperson of the Nominating and Corporate Governance Committee and lead independent director. His departure is amicable, with no disputes over company operations, policies, or practices. Alexander Timm is set to take over as the new lead independent director.
Find detailed analytics on GOCO stock on TipRanks’ Stock Analysis page.